demonstrated that the FASN expression is higher in tumors growing in brain tissue than in extracranial tissues, with a concomitant increase in de novo fatty acid synthesis, while genetic and pharmacological inhibition of FASN has more inhibitory effect on breast cancer growth in the brain than in lipid-rich issues. This evidence concerns the gene FASN and breast carcinoma.